Epoetin beta: Encyclopedia with 57,945 entries from biotech, medicine & life sciences.

Epoetin beta

Epoetin beta
Systematic (IUPAC) name
?
Identifiers
CAS number	?
ATC code	?
PubChem	?
Chemical data
Formula	?
Mol. mass	?
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Epoetin beta (rINN) (pronounced /ɛˈpoʊɨtɨn/) is a synthetic, recombinant^[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.

Epoetin is marketed under the trade names NeoRecormon.^[2] It is only sold in Europe.

References

^ Dunn CJ, Markham A (1996). "Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure". Drugs 51 (2): 299–318. PMID 8808169.
^ Amgen - Products. URL: http://www.amgen.com/patients/prca.html. Accessed on: October 21, 2007.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Epoetin_beta". A list of authors is available in Wikipedia.